glp-1 pet scan imaging news drugs may confound PET/CT findings ARRS: Do GLP-1 drugs confound

How would you manage a patient taking a GLP-1 agonist for weight loss who continues to have symptoms (i.e., nausea, vomiting) related to reduced GI motility despite dose adjustments

The city also carries a deep bariatric heritage

Further, small changes in lipid parameters and DBP were noted over 12 months, with moderate improvements in SBP

Where direct verification links are available, customers can review supporting documentation before ordering

[DOI] [PMC free article] [PubMed] [Google Scholar] 13.Chen J, Mei A, Wei Y, Li C, Qian H, Min X, et al

Chronic obstructive pulmonary disease, lung function and risk of type 2 diabetes: a systematic review and meta-analysis of cohort studies